Mycenax Biotech Inc. (TPEX:4726)
Taiwan
· Delayed Price · Currency is TWD 32.60
-0.45 (-1.36%)
Mar 10, 2026, 9:34 AM CST
Mycenax Biotech Revenue
Mycenax Biotech had revenue of 131.37M TWD in the quarter ending September 30, 2025, a decrease of -37.18%. This brings the company's revenue in the last twelve months to 649.64M, down -3.45% year-over-year. In the year 2024, Mycenax Biotech had annual revenue of 683.92M with 4.80% growth.
Revenue (ttm)
649.64M
Revenue Growth
-3.45%
P/S Ratio
10.54
Revenue / Employee
1.68M
Employees
387
Market Cap
6.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 683.92M | 31.30M | 4.80% |
| Dec 31, 2023 | 652.62M | -79.66M | -10.88% |
| Dec 31, 2022 | 732.28M | -41.99M | -5.42% |
| Dec 31, 2021 | 774.27M | 108.93M | 16.37% |
| Dec 31, 2020 | 665.34M | 274.50M | 70.23% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Acepodia | 301.00K |
| Adimmune | 1.20B |
| Savior Lifetec | 1.16B |
| TaiGen Biopharmaceuticals Holdings | 38.75M |
| Sinphar Pharmaceutical | 3.35B |
| PharmaEngine | 2.51B |
| AnnJi Pharmaceutical | 23.85M |
| CHO Pharma | 3.21M |